LBI-HTA - Publications - Search - Subject: WK 500-590 Pituitary gland
Number of items at this level: 4.

Adlbrecht, C. and Wild, C. (2010): Radionuclide therapy - 90Yttrium and 177Lutetium somatostatin analogues for the treatment of inoperable neuroendocrine tumors. Decision Support Document 40.

Adlbrecht, C. and Wild, C. (2007): [Targeted radionuclide therapy with 90Y- and 177-Lu-DOTATOC in patients with neuroendocrine tumors. HTA in hospitals]. Decision Support Document 02.

Wild, C. (2003): [Recombinant human growth hormone (GH) therapy]. HTA-Newsletter 21: 2.

Wild, C. and Adlbrecht, C. (2007): [Radiopharmaceuticals in palliative care]. HTA-Newsletter 58: 2-3.

This list was generated on Sun Dec 17 05:00:44 2017 CET.